S&P 500 could push even higher by end of year: Chart of the Day
The S&P 500 (^GSPC) is inching closer to record highs after recovering losses tied to tariff fears. Yahoo Finance anchor Julie Hyman joins Asking for a Trend in today's Chart of the Day to go over different analysts' year-end targets for the index and to explain why investors are eyeing 6,144 as the next key level for the S&P 500.
To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here.
In today's chart of the day, we are keeping it straightforward. We are once again approaching the record high for the S&P 500 to see just how close. That's what I wanted to illustrate here today. So here we're just looking at a very straightforward uh year-to-date chart of the S&P 500. We're up a little bit on the year, but really not much changed. What's important here is the clawback that we have seen from the depths here uh where we saw tariff related losses. And because, as many investors have said to us, the worst case scenario of the most onerous, the highest tariffs on our trading partners, seems as though that worst case has been removed, at least for now. That is what has allowed stocks to rally from here. So here was the record high for the S&P 500 that was back on February 19th specifically. Since then to today, we see about a 2 and a quarter percent decline. So we're about 2 and a quarter percent from that record high level. Um and many of the investors, strategists that we've been speaking with, even as recently as today, have said they are optimistic. We could push higher from here. It's going to depend on things like getting those trade deals further down the line, seeing what happens with the tax bill that is making its way through Congress, and what does the Fed do next? Is it indeed going to cut rates once or twice before the end of the year? So those are the various things that investors are watching most closely here. In terms of where strategists are for year end for the S&P 500, there is a wide, wide dispersion that has remained in place really throughout the year. Wells Fargo at 7,000, I don't even know where that would be on this chart somewhere up there. And then the lowest uh estimate on the street is with Stifel Nicholas. That's at 5,500, so around here or so. So very broad range of outcomes. If you look at the median of those outcomes, you get 6,100, which is just a little bit above where we are today, and obviously would imply a new record for the average. So what's interesting about that 6,100, that median, is that since we saw the sort of tariff pause with China, many of those uh forecasts have been increased. The likes of Ed Yardeni at Yardeni Research, Goldman Sachs, Deutsche Bank, City and Barclays have been raising their forecasts. Remember, they many of them cut as we saw those worst case scenarios being baked in, and then they raised when it looked like that that was removed. But when we're talking what to watch here, 614415, that was the closing record on February 19th. That is the next number to watch, Josh.
Thank you, Julie.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Mesoblast (ASX:MSB) Gains 15% In One Week With US FDA Orphan-Drug Approval
Mesoblast experienced a 15% increase in its share price over the past week, largely driven by a significant orphan-drug approval by the U.S. FDA for Ryoncil. This approval, granting seven years of exclusivity for a vital treatment, likely bolstered investor confidence given the strengthened competitive positioning of Mesoblast. While broader market trends saw the S&P 500 and Nasdaq reach new highs amid positive investor sentiment on U.S.-China trade discussions, Mesoblast's specific gains were more tied to its unique developments, as they provided a substantial boost, counterbalancing broader market movements. You should learn about the 1 warning sign we've spotted with Mesoblast. Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. Over the past three years, Mesoblast's total shareholder return, including share price changes and dividends, reached 181.00%. Despite recent gains driven by the U.S. FDA's orphan-drug approval for Ryoncil, the company's one-year performance outpaced the broader Australian Biotechs industry, which returned 12.3% less in the same timeframe. This highlights significant investor confidence and a positive reception to recent strategic advancements. While Mesoblast's share price has experienced impressive growth, it still trades at approximately 88% below consensus analyst price targets. The approval of Ryoncil positions the company competitively, potentially boosting future revenue, as evidenced by the expanded insurance coverage to 104 million U.S. lives. However, Mesoblast remains unprofitable, with A$47.93 million in net losses reported in its recent earnings. Analysts forecast substantial revenue growth at 56.7% annually, but profit forecasts show continued challenges for the next three years. The stock's recent appreciation reflects increased optimism, although the gap between the current share price and targeted fair value suggests room for further market adjustments. Our comprehensive valuation report raises the possibility that Mesoblast is priced lower than what may be justified by its financials. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:MSB. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CBS News
23 minutes ago
- CBS News
Bay Area solar owners could see tax credits slashed under Trump's spending bill
The budget bill being debated in Congress could have serious implications for a lot of industries, but some are saying it could be a disaster for the residential solar industry. Solar companies are already hurting from reductions in government subsidies, but a threat to eliminate the federal solar tax credit could be putting the industry on the verge of collapse. Solar power itself is a proven technology with a lot of benefits to offer as a clean, renewable source of energy. But right now, a lot of energy is going into just keeping the business alive. "I think the industry is going to go through some very hard times," said Severin Borenstein, faculty director at UC Berkeley's Haas Energy Institute. He said rooftop solar has gone through a lot of changes in the last few years, with the State reducing how much solar system owners are credited for the energy they produce. But lately things have been improving. "2024 was back to 2021 levels, so they had really recovered from a drop," said Borenstein. "But now, with what the Trump administration is doing, I think there's a lot of concern. There were already a lot of rooftop solar companies that had pretty tenuous financing and were having a hard time. And I think this is pushing some of them over the edge." He was talking about a Republican effort in the budget bill to eliminate the 30 percent federal tax credit given to people who install solar systems on their homes. That, along with the tariffs being imposed by President Trump, has solar industry insiders calling foul. "It's really sad to see solar energy being caught in partisan crosshairs," said Brad Heavner, executive director of the California Solar and Storage Association. "The sun is not Republican or Democrat. The need for more electricity is not Democrat or Republican. We need more energy in America and Congress has a role to play in making that happen." But right now, the role Congress is playing is to restrict rooftop solar, along with other renewable energies, in favor of older sources like fossil fuels and coal. The effect has already been devastating, with solar companies going bankrupt across the country. On Monday, solar giant Sunnova Energy filed for protection and last week, Solar Mosaic, a major lender in the business, also went belly up. But Gordon Johnson, founder of a research firm studying the industry, said the companies may have brought it on themselves simply by the way they did business. He said some misrepresented their costs to lenders in what he compared to a Ponzi Scheme. "The solar industry in the US is in a state of significant disarray. And it's not something that could not have been predicted," said Johnson. "They perpetually issue debt. These companies are always issuing debt. As soon as they can't issue debt, and they can't plug that hole of the actual cost of the system versus what they show Wall Street, they quickly go bankrupt." Higher interest rates and equipment cost inflation have also figured into the mix. One analysis found that, nationwide, more than $14 billion in clean energy and electric vehicles have been cancelled or delayed as a result. The prospects for the industry aren't good right now, but Joe Osha, an analyst for investment banker Guggenheim Securities, said rooftop solar should not be confused with the overall solar energy market. "In megawatt terms, I can tell you that the residential solar business, as visible as it is, is only a tiny fraction of the solar generation that gets added into this country each year," said Osha. "The vast majority of it are these large utility-scale solar farms. I don't see any scenario under which that utility-scale solar business collapses." That leaves residential solar twisting in the political wind. And experts are saying small companies that have been the backbone of California's solar revolution will have a hard time staying in business.
Associated Press
38 minutes ago
- Associated Press
Asian shares are mixed as markets shrug at latest China-US trade deal
TOKYO (AP) — Asian shares were trading mixed early Thursday after Wall Street's rally stalled as investors appeared not to react much to the results of the latest round of China-U.S. trade talks. U.S. futures slipped while oil prices rose. Japan's Nikkei 225 lost 0.7% to 38,160.80. Hong Kong's Hang Seng sank 0.7% to 24,206.69, while the Shanghai Composite index edged 0.1% lower to 3,400.30. In South Korea, the Kospi gained 0.4% to 2,919.67, while Australia's S&P/ASX 200 edged 0.1% higher to 8,604.70. On Wednesday, the S&P 500 fell 0.3% to 6,022.24 for its first loss in four days. The Dow Jones Industrial Average was virtually unchanged at 42,865.77 after edging down by 1 point. The Nasdaq composite slipped 0.5% to 3,400.30. All told, the S&P 500 fell 16.57 points to 6,022.24. The Dow Jones Industrial Average slipped 1.10 to 42,865.77, and the Nasdaq composite sank 99.11 to 19,615.88. Several Big Tech stocks led the way lower, and a 1.9% drop for Apple was the heaviest weight on the market. It's been listless this week after unveiling several modest upcoming changes to the software that runs its devices. The action was stronger in the bond market, where Treasury yields eased after a report suggested President Donald Trump's tariffs are not pushing inflation much higher, at least not yet. U.S. consumers had to pay prices for food, gasoline and other costs of living that were 2.4% higher overall in May than a year earlier. That was up from April's 2.3% inflation rate, but it wasn't as bad as the 2.5% that Wall Street was expecting. A fear has been that Trump's wide-ranging tariffs could ignite an acceleration in inflation, just when it had seemed to get nearly all the way back to the Federal Reserve's 2% target from more than 9% three summers ago. It hasn't happened, though economists warn it may take months more to feel the full effect of Trump's tariffs. Trump said Wednesday that China will supply rare-earth minerals and magnets to the United States, while his government will allow Chinese students into U.S. universities in a deal that still needs an agreement by him and by China's leader. Trump also said that 'President XI and I are going to work closely together to open up China to American Trade. This would be a great WIN for both countries!!!' Investors are still hoping for a more sweeping trade deal that would ease tensions between the world's two largest economies. Hopes for such deals between the United States and countries around the world have been one of the main reasons the S&P 500 has charged nearly all the way back to its all-time high after dropping roughly 20% below a couple months ago. Without them, the fear is that Trump's high tariffs could drive the economy into a recession while pushing inflation higher. The S&P 500 is now sitting 2% below its record. Tesla swung between gains and losses before finishing with a rise of 0.1% to continue its shaky run. It's been recovering much of its big losses taken last week after Elon Musk's relationship with Trump imploded, which in turn raised fears about a loss of business for the electric-vehicle company. Musk on Wednesday backed away from some of his earlier comments and said they went 'too far.' In the bond market, the yield on the 10-year Treasury eased to 4.41% from 4.47% late Tuesday. Shorter-term yields, which more closely track expectations for what the Fed will do with overnight interest rates, fell more. Wednesday's better-than-expected reading on inflation raised expectations along Wall Street that the Fed could cut its main interest rate at least twice by the end of the year. In other dealings early Thursday, U.S. benchmark crude oil gained 13 cents to $68.28 per barrel. Brent crude, the international standard, picked up 10 cents to $69.87 per barrel. The U.S. dollar slipped to 144.05 Japanese yen from 144.60 yen. The euro rose to $1.1521 from $1.1487. ___ AP Business Writer Stan Choe contributed.
